41 related articles for article (PubMed ID: 15039071)
1. Development of a back-titration assay to quantitate functional lympho-epithelial Kazal-type inhibitors (LEKTI) in skin samples.
Martins D; Pinoteau MA; Leger R
Anal Biochem; 2024 Jul; 690():115524. PubMed ID: 38556114
[TBL] [Abstract][Full Text] [Related]
2. New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI.
Bennett K; Callard R; Heywood W; Harper J; Jayakumar A; Clayman GL; Di WL; Mills K
J Proteome Res; 2010 Aug; 9(8):4289-94. PubMed ID: 20533828
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI).
Schechter NM; Choi EJ; Wang ZM; Hanakawa Y; Stanley JR; Kang Y; Clayman GL; Jayakumar A
Biol Chem; 2005 Nov; 386(11):1173-84. PubMed ID: 16307483
[TBL] [Abstract][Full Text] [Related]
4. SPINKs in Tumors: Potential Therapeutic Targets.
Liao C; Wang Q; An J; Zhang M; Chen J; Li X; Xiao L; Wang J; Long Q; Liu J; Guan X
Front Oncol; 2022; 12():833741. PubMed ID: 35223512
[TBL] [Abstract][Full Text] [Related]
5. Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency.
Stuvel K; Heeringa JJ; Dalm VASH; Meijers RWJ; van Hoffen E; Gerritsen SAM; van Zelm MC; Pasmans SGMA
Allergy; 2020 Jul; 75(7):1710-1720. PubMed ID: 31975472
[TBL] [Abstract][Full Text] [Related]
6. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
7. KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype.
Kasparek P; Ileninova Z; Zbodakova O; Kanchev I; Benada O; Chalupsky K; Brattsand M; Beck IM; Sedlacek R
PLoS Genet; 2017 Jan; 13(1):e1006566. PubMed ID: 28095415
[TBL] [Abstract][Full Text] [Related]
8. Netherton Syndrome: A Genotype-Phenotype Review.
Sarri CA; Roussaki-Schulze A; Vasilopoulos Y; Zafiriou E; Patsatsi A; Stamatis C; Gidarokosta P; Sotiriadis D; Sarafidou T; Mamuris Z
Mol Diagn Ther; 2017 Apr; 21(2):137-152. PubMed ID: 27905021
[TBL] [Abstract][Full Text] [Related]
9. The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10.
Jefferson T; Auf dem Keller U; Bellac C; Metz VV; Broder C; Hedrich J; Ohler A; Maier W; Magdolen V; Sterchi E; Bond JS; Jayakumar A; Traupe H; Chalaris A; Rose-John S; Pietrzik CU; Postina R; Overall CM; Becker-Pauly C
Cell Mol Life Sci; 2013 Jan; 70(2):309-33. PubMed ID: 22940918
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.
Eissa A; Amodeo V; Smith CR; Diamandis EP
J Biol Chem; 2011 Jan; 286(1):687-706. PubMed ID: 20940292
[TBL] [Abstract][Full Text] [Related]
11. Inhibition mechanism and the effects of structure on activity of male reproduction-related peptidase inhibitor Kazal-type (MRPINK) of Macrobrachium rosenbergii.
Li Y; Qian YQ; Ma WM; Yang WJ
Mar Biotechnol (NY); 2009; 11(2):252-9. PubMed ID: 18795369
[TBL] [Abstract][Full Text] [Related]
12. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.
Deraison C; Bonnart C; Lopez F; Besson C; Robinson R; Jayakumar A; Wagberg F; Brattsand M; Hachem JP; Leonardsson G; Hovnanian A
Mol Biol Cell; 2007 Sep; 18(9):3607-19. PubMed ID: 17596512
[TBL] [Abstract][Full Text] [Related]
13. A two disulfide bridge Kazal domain from Phytophthora exhibits stable inhibitory activity against serine proteases of the subtilisin family.
Tian M; Kamoun S
BMC Biochem; 2005 Aug; 6():15. PubMed ID: 16117831
[TBL] [Abstract][Full Text] [Related]
14. A Second Kazal-like protease inhibitor from Phytophthora infestans inhibits and interacts with the apoplastic pathogenesis-related protease P69B of tomato.
Tian M; Benedetti B; Kamoun S
Plant Physiol; 2005 Jul; 138(3):1785-93. PubMed ID: 15980196
[TBL] [Abstract][Full Text] [Related]
15. Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A.
Jayakumar A; Kang Y; Mitsudo K; Henderson Y; Frederick MJ; Wang M; El-Naggar AK; Marx UC; Briggs K; Clayman GL
Protein Expr Purif; 2004 May; 35(1):93-101. PubMed ID: 15039071
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
Mitsudo K; Jayakumar A; Henderson Y; Frederick MJ; Kang Y; Wang M; El-Naggar AK; Clayman GL
Biochemistry; 2003 Apr; 42(13):3874-81. PubMed ID: 12667078
[TBL] [Abstract][Full Text] [Related]
17. LEKTI domain 15 is a functional Kazal-type proteinase inhibitor.
Vitzithum K; Lauber T; Kreutzmann P; Schulz A; Sommerhoff CP; Rösch P; Marx UC
Protein Expr Purif; 2008 Jan; 57(1):45-56. PubMed ID: 17936012
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
